Evidence map›Paper›PMID 36363991›Full record

ReviewMolecules (Basel, Switzerland)2022

Transition Metal-(μ-Cl)-Aluminum Bonding in α-Olefin and Diene Chemistry.

Ilya E Nifant'ev, Ildar I Salakhov, Pavel V Ivchenko

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanism of Action of MAO'sACS catalysis · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ilya E Nifant'evA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences (RAS), 29 Leninsky Pr., 119991 Moscow, Russia.ORCID 0000-0001-9151-1890
Ildar I SalakhovA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences (RAS), 29 Leninsky Pr., 119991 Moscow, Russia.ORCID 0000-0003-0288-2660
Pavel V IvchenkoA.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences (RAS), 29 Leninsky Pr., 119991 Moscow, Russia.ORCID 0000-0002-0181-5952
Russian Academy of Sciences · RU

Funding

Russian Science Foundation 21-73-30010
6 · The paper itself

Abstract

Olefin and diene transformations, catalyzed by organoaluminum-activated metal complexes, are widely used in synthetic organic chemistry and form the basis of major petrochemical processes. However, the role of M−(μ-Cl)−Al bonding, being proven for certain >C=C< functionalization reactions, remains unclear and debated for essentially more important industrial processes such as oligomerization and polymerization of α-olefins and conjugated dienes. Numerous publications indirectly point at the significance of M−(μ-Cl)−Al bonding in Ziegler−Natta and related transformations, but only a few studies contain experimental or at least theoretical evidence of the involvement of M−(μ-Cl)−Al species into catalytic cycles. In the present review, we have compiled data on the formation of M−(μ-Cl)−Al complexes (M = Ti, Zr, V, Cr, Ni), their molecular structure, and reactivity towards olefins and dienes. The possible role of similar complexes in the functionalization, oligomerization and polymerization of α-olefins and dienes is discussed in the present review through the prism of the further development of Ziegler−Natta processes and beyond.

Indexed as

carboaluminationDFTdienesheterobimetallic complexeshydroaluminationmetallocenesmethylenealkanesolefinsoligomerizationpolymerizationpolyolefinssingle-site catalystsZiegler–Natta catalysts

Identifiers

PMID36363991
PMCPMC9654437
OpenAlexW4307270128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.